{
    "2020-07-16": [
        [
            {
                "time": "2023-10-05",
                "original_text": "The Daily Biotech Pulse: Mallinckrodt Gets FDA Panel Backing, Regulatory Setback For Tricida, Relay Therapeutics IPO",
                "features": {
                    "keywords": [
                        "FDA Panel Backing",
                        "Regulatory Setback",
                        "Relay Therapeutics IPO"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Novartis To Sell Covid-19 Drugs At Zero-Profit To Low-Income Countries",
                "features": {
                    "keywords": [
                        "Covid-19 Drugs",
                        "Zero-Profit",
                        "Low-Income Countries"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Novartis to provide 'no profit' COVID-19 drugs to low income countries",
                "features": {
                    "keywords": [
                        "No Profit",
                        "COVID-19 drugs",
                        "Low Income Countries"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19",
                "features": {
                    "keywords": [
                        "Not-for-profit",
                        "Portfolio",
                        "Symptomatic Treatment",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Stocks - Europe Seen Lower Ahead of ECB Meeting",
                "features": {
                    "keywords": [
                        "Europe",
                        "ECB Meeting",
                        "Lower"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "economy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}